Crossmark

Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy

Crossref DOI link: https://doi.org/10.1016/j.celrep.2019.07.060

Published Print: 2019-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Wu, Tiffany

Dejanovic, Borislav

Gandham, Vineela D.

Gogineni, Alvin

Edmonds, Rose

Schauer, Stephen

Srinivasan, Karpagam

Huntley, Melanie A.

Wang, Yuanyuan

Wang, Tzu-Ming

Hedehus, Maj

Barck, Kai H.

Stark, Maya

Ngu, Hai

Foreman, Oded

Meilandt, William J.

Elstrott, Justin

Chang, Michael C.

Hansen, David V.

Carano, Richard A.D.

Sheng, Morgan

Hanson, Jesse E.
License Information

Text and Data Mining valid from 2019-08-01

Text and Data Mining valid from 2019-08-01

Version of Record valid from 2019-07-20
More Information

This article is maintained by: Elsevier

Article Title: Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy

Journal Title: Cell Reports

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.celrep.2019.07.060

Content Type: article

Copyright: © 2019 The Author(s).